Shin, Keewon http://orcid.org/0000-0002-5028-5716
Lee, Jung Su http://orcid.org/0000-0001-5644-0150
Lee, Ji Young http://orcid.org/0000-0002-0764-615X
Lee, Hyunsu http://orcid.org/0000-0003-3631-3028
Kim, Jeongseok http://orcid.org/0000-0003-1007-564X
Byeon, Jeong-Sik http://orcid.org/0000-0002-9793-6379
Jung, Hwoon-Yong
Kim, Do Hoon http://orcid.org/0000-0002-4250-4683
Kim, Namkug http://orcid.org/0000-0002-3438-2217
Funding for this research was provided by:
Korea Health Industry Development Institute (HI18C0022)
Article History
Received: 5 April 2022
Revised: 21 February 2023
Accepted: 23 February 2023
First Online: 13 March 2023
Declarations
:
: This retrospective study was conducted according to the principles of the Declaration of Helsinki and was performed in accordance with current scientific guidelines. The study protocol was approved by the Institutional Review Board Committee of Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (IRB No. 2020–0568). The requirement for informed patient consent was waived by the Institutional Review Board Committee of Asan Medical Center.
: The authors except Namkug Kim have no conflicts of interest to disclose. Namkug Kim is a stakeholder of Promedius Inc.